학술논문

Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged
Document Type
Article
Source
In European Journal of Surgical Oncology September 2019 45(9):1660-1667
Subject
Language
ISSN
0748-7983